Inflammatory bowel disease (IBD) is a chronic immune-mediated disease affecting the
gastrointestinal tract. IBD consists of 2 subtypes: ulcerative colitis and Crohn disease. IBD is …

Although the number of available therapies for the treatment of ulcerative colitis and Crohn's
disease (CD) continues to expand, a significant portion of patients with inflammatory bowel …

Background The gut microbiota plays a central role in host physiology and in several
pathological mechanisms in humans. Antibiotics compromise the composition and functions …

The American Society of Colon and Rectal Surgeons (ASCRS) is dedicated to ensuring high-
quality patient care by advancing the science, prevention, and management of disorders …

Background Numerous studies have examined the gut microbial ecology of patients with
Crohn's disease (CD) and ulcerative colitis, but inflammatory bowel disease–associated …

With the development of microbiology and metabolomics, the relationship between the
intestinal microbiome and intestinal diseases has been revealed. Fecal microbiota …

Inflammatory bowel disease (IBD) is a chronic immune-mediated disease that affects the
gastrointestinal tract. It is argued that environment, microbiome, and immune-mediated …

Abstract Background and Aims Adequate endoscopic scoring in Crohn's disease [CD] is
crucial, as it dictates the need for initiating postoperative medical therapy and is utilized as …

Crohn's disease (CD) and ulcerative colitis (UC) are relapsing and remitting chronic
inflammatory diseases of the gastrointestinal tract. Although surgery for UC can provide a …

Background Microbial factors are likely to be involved in the recurrence of Crohn's disease
(CD) after bowel resection. We investigated the luminal microbiota before and longitudinally …